These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4853252)

  • 1. Monitoring contamination levels of in-use intravenous solutions using "total sample" techniques.
    Hanson AL; Shelley RM
    Am J Hosp Pharm; 1974 Aug; 31(8):733-5. PubMed ID: 4853252
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbiologic quality assurance for intravenous admixtures in a small hospital.
    Doss HL; James JD; Killough DM; Snodgrass GL
    Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining a time frame for sterility testing of intravenous admixtures.
    DeChant RL; Furtado D; Smith FM; Godwin HN; Domann DE
    Am J Hosp Pharm; 1982 Aug; 39(8):1305-8. PubMed ID: 6751079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of three methods for detecting low-level bacterial contamination in intravenous solutions.
    Miller CM; Furtado D; Smith FM; Godwin HN; Hogan LC; Letendre DE
    Am J Hosp Pharm; 1982 Aug; 39(8):1302-5. PubMed ID: 6812414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixing of additives in glass and plastic intravenous fluid containers.
    Bighley LD; Wille J; Lach JL
    Am J Hosp Pharm; 1974 Aug; 31(8):736-9. PubMed ID: 4853231
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of the first 6 months' experience in the monitoring of the sterility of injectable solutions].
    Pappalardo G
    Rev Med Suisse Romande; 1986 Feb; 106(2):163-71. PubMed ID: 3515496
    [No Abstract]   [Full Text] [Related]  

  • 7. Plastic containers for intravenous solutions.
    Med Lett Drugs Ther; 1975 May; 17(10):43-4. PubMed ID: 1128439
    [No Abstract]   [Full Text] [Related]  

  • 8. Contamination of intravenous solutions by airborne microbes.
    Hansen JS; Hepler CD
    Am J Hosp Pharm; 1973 Apr; 30(4):326-31. PubMed ID: 4697656
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of three methods for detecting bacterial contamination in intravenous solutions.
    Hoffman KH; Smith FM; Godwin HN; Hogan LC; Furtado D
    Am J Hosp Pharm; 1982 Aug; 39(8):1299-302. PubMed ID: 6751078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particulate-matter content of D5/NS for injection: manufacturer difference and conformance with USP limits.
    Smith JK; Baumann RR; Gunning WT; Annancy L; Alexander KS
    J Parenter Sci Technol; 1988; 42(6):180-6. PubMed ID: 3273493
    [No Abstract]   [Full Text] [Related]  

  • 12. Particles in intravenous solutions: a review.
    Thomas WH; Lee YK
    N Z Med J; 1974 Aug; 80(522):170-8. PubMed ID: 4608302
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of two methods for detecting microbial contamination in intravenous fluids.
    Posey LM; Nutt RE; Thomson PD
    Am J Hosp Pharm; 1981 May; 38(5):659-62. PubMed ID: 6792910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particulate matter in intravenous infusion fluids--phase 3.
    Turco SJ; Davis NM
    Am J Hosp Pharm; 1973 Jul; 30(7):611-3. PubMed ID: 4715106
    [No Abstract]   [Full Text] [Related]  

  • 15. Elimination of particulate contamination from ophthalmic solutions for intraocular surgery.
    Jaffe NS
    Bull Parenter Drug Assoc; 1970; 24(5):218-25. PubMed ID: 5471332
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress toward a preferred method of monitoring the sterility of intravenous admixtures.
    Akers MJ
    Am J Hosp Pharm; 1982 Aug; 39(8):1297. PubMed ID: 6751077
    [No Abstract]   [Full Text] [Related]  

  • 17. [The origin of particulate contamination in injectable solutions].
    Lambert G; Moës A
    J Pharm Belg; 1972; 27(4):402-16. PubMed ID: 4681074
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of the safety and efficiency of three intermittent intravenous therapy systems--the minibottle, the minibag and the inline burette.
    McAllister JC; Buchanan EC; Skolaut MW
    Am J Hosp Pharm; 1974 Oct; 31(10):961-7. PubMed ID: 4216266
    [No Abstract]   [Full Text] [Related]  

  • 19. Some size distributions of particulate contamination found in commercially available intravenous fluids.
    Groves MJ
    J Pharm Pharmacol; 1966 Mar; 18(3):161-7. PubMed ID: 4381212
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of particulate matter in I.V. infusion fluids.
    Davis NM; Turco S; Sivelly E
    Am J Hosp Pharm; 1970 Oct; 27(10):822-6. PubMed ID: 5473472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.